美托洛尔联合稳心颗粒治疗老年缺血性心律失常的效果观察

Study on the effect of metatolol on the treatment of ischemic arrhythmia in elderly patients

目的:浅析美托洛尔联合稳心颗粒治疗老年缺血性心律失常的效果。方法:随机选取本院于2016年5月至2017年6月收治的60例缺血性心律失常的老年患者作为研究对象,与此同时按照随机数字法分成实验组与对照组,两组病患均为30例。对照组患者仅予以美托洛尔进行治疗,而实验组予以美托洛尔联用稳心颗粒进行治疗,对比两组的治疗效果与并发症状况并作评价。结果:经过不同治疗之后,实验组病患的治疗总有效率为93.33%,而对照组的治疗总有效率为76.67%,两组之间差异显著(P<0.05);实验组病患的不良反应率有3.33%;对照组不良反应率是16.67%,组间差异具显著性(P<0.05)。结论:美托洛尔联合稳心颗粒用于老年缺血性心律失常的治疗效果十分显著,病患治疗后并发症的发生率显著下降,生活质量也得到改善,具有较高的推广价值。

Objective:Analyses metoprolol combined metacentric granules for the treatment of senile ischemic arrhythmias.Methods:Randomly selected in our hospital from May 2016 to June 2017 were 60 cases of elderly patients with ischemic arrhythmias as the research object,at the same time,in accordance with the method of random Numbers were divided into experimental group and control group,two groups of patients were 30 cases.Control group patients give only metoprolol treatment,and the experimental group with metoprolol combined metacentric granule treatment,compared two groups of therapeutic effect and complications and evaluation.Result:After different treatment,the patient’s treatment the total effective rate was 93.33%,and the treatment of control group total effective rate was 76.67%,significant difference between two groups(P < 0.05);The experimental group patients adverse reaction rate is 3.33%;Control group adverse reaction rate is 16.67%,with significant difference between groups(P < 0.05).Conclusion:Metoprolol combined metacentric particles used in are very effective in the treatment of senile ischemic arrhythmias,a significant reduction in the incidence of complications after treatment,patients quality of life is improved,is of high popularization value.